Peel Hunt Boosts ConvaTec Group (LON:CTEC) Price Target to GBX 280
ConvaTec Group (LON:CTEC) had its target price upped by Peel Hunt from GBX 230 ($3.01) to GBX 280 ($3.66) in a research report released on Monday morning, ThisIsMoney.Co.Uk reports. The firm currently has a buy rating on the stock.
A number of other analysts have also weighed in on the stock. Numis Securities reiterated a buy rating and issued a GBX 200 ($2.61) price objective on shares of ConvaTec Group in a research note on Friday, May 3rd. UBS Group increased their price objective on shares of ConvaTec Group from GBX 129 ($1.69) to GBX 185 ($2.42) and gave the stock a neutral rating in a research note on Tuesday, August 6th. Barclays reiterated an equal weight rating and issued a GBX 130 ($1.70) price objective (down previously from GBX 148 ($1.93)) on shares of ConvaTec Group in a research note on Wednesday, April 17th. JPMorgan Chase & Co. increased their price objective on shares of ConvaTec Group from GBX 132 ($1.72) to GBX 174 ($2.27) and gave the stock a neutral rating in a research note on Monday, August 5th. Finally, Deutsche Bank reiterated a sell rating on shares of ConvaTec Group in a research note on Friday, July 12th. One research analyst has rated the stock with a sell rating, five have issued a hold rating and four have issued a buy rating to the company’s stock. ConvaTec Group currently has an average rating of Hold and an average target price of GBX 169.30 ($2.21).
LON:CTEC opened at GBX 180.90 ($2.36) on Monday. The firm has a market capitalization of $3.58 billion and a P/E ratio of 22.61. ConvaTec Group has a 1-year low of GBX 113.25 ($1.48) and a 1-year high of GBX 240.50 ($3.14). The company’s fifty day moving average price is GBX 158.25 and its 200-day moving average price is GBX 143.36. The company has a debt-to-equity ratio of 104.76, a current ratio of 2.37 and a quick ratio of 1.58.
ConvaTec Group Company Profile
ConvaTec Group Plc develops, manufactures, and markets medical products and technologies worldwide. It offers advanced wound dressings and skin care products for the management of chronic wounds resulting from various conditions, such as diabetes, immobility, and venous disease, as well as for traumatic injury, burns, invasive surgery, and other causes.
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.